NYSE Updates Palantir’s stock draws a downgrade over its ‘gluttonous valuation’ By Admin June 21, 2024 0 51 Share FacebookTwitterPinterestWhatsApp Must read The Dodgers Just Bought Another World Series Contender—And They’re Not Apologizing January 31, 2025 Rising electricity demand could mean more fossil fuels – for now » Yale Climate Connections January 31, 2025 Lucky & Elizabeth Scheme Pays Off January 31, 2025 AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5% January 31, 2025 Adminhttps://newschatspot.com An analyst thinks Palantir will see AI benefits but deems the stock’s valuation to be steep on a relative basis and given industry pressures. Admin (8) Share FacebookTwitterPinterestWhatsApp Previous articleWarner makes yet another move in South East Europe with investment in Croatian label Dancing BearNext articleSan Fransico Giants Add #24 Memorial Patch for Willie Mays – SportsLogos.Net News More articles AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5% January 31, 2025 EU restarts Rafah border crossing mission, says EU foreign policy chief Kallas January 31, 2025 Intel shows signs of progress in the face of another revenue decline January 31, 2025 Latest article The Dodgers Just Bought Another World Series Contender—And They’re Not Apologizing January 31, 2025 Rising electricity demand could mean more fossil fuels – for now » Yale Climate Connections January 31, 2025 Lucky & Elizabeth Scheme Pays Off January 31, 2025 AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5% January 31, 2025 Apple rises as rosy forecast lifts hopes for iPhone rebound January 31, 2025
